Simpler Grants.gov #359724

NIH Grant Forecast: Early-Career Scientist Transition to Small Business Entrepreneurship

This opportunity is a forecasted grant from the National Institutes of Health (NIH), specifically involving the National Cancer Institute (NCI), National Human Genome Research Institute (NHGRI), and National Institute of Biomedical Imaging and Bioengineering (NIBIB). - Purpose: Support early-career academic scientists transitioning to entrepreneurship and facilitate technology transfer from academic labs to small businesses - Program utilizes the R41/R42 activity code (SBIR/STTR) - Focus areas include: - Innovative technology development for cancer detection - Human genome research - Applied health technology innovations - Key support provided: - Entrepreneurial mentoring - Product development assistance - No specific OEMs, vendors, or product part numbers are named, as this is a grant for research and development - Eligible applicants: government entities, educational institutions, nonprofits, and small businesses - Unique requirements: - Emphasis on team expertise development and early-stage technology transfer - Designed to address challenges in moving academic research into commercial small business settings

Description

The National Cancer Institute (NCI), along with the National Human Genome Research Institute (NHGRI) and National Institute of Biomedical Imaging and Bioengineering (NIBIB), plans to publish a Notice of Funding Opportunity to support early-career academic scientists transitioning to entrepreneurship and facilitate technology transfer from academic labs to small businesses. The program aims to address challenges in team expertise and early-stage technology development by providing entrepreneurial mentoring and product development support. This funding opportunity will use the R41/R42 activity code and is expected to be published in Summer 2025 with applications due in Fall 2025. The grant supports innovative technology development through SBIR and STTR programs, focusing on cancer detection, human genome research, and applied health technology innovations.

View original listing